Mutual of America Capital Management LLC Has $275,000 Holdings in STAAR Surgical (NASDAQ:STAA)

Mutual of America Capital Management LLC reduced its position in STAAR Surgical (NASDAQ:STAA) by 72.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,396 shares of the medical instruments supplier’s stock after selling 19,063 shares during the quarter. Mutual of America Capital Management LLC’s holdings in STAAR Surgical were worth $275,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Arcadia Investment Management Corp MI bought a new stake in STAAR Surgical during the third quarter worth about $37,000. Canada Pension Plan Investment Board bought a new stake in shares of STAAR Surgical during the second quarter worth $129,000. Van ECK Associates Corp lifted its position in STAAR Surgical by 12.7% during the 3rd quarter. Van ECK Associates Corp now owns 3,478 shares of the medical instruments supplier’s stock valued at $129,000 after purchasing an additional 393 shares during the period. Larson Financial Group LLC bought a new position in STAAR Surgical in the second quarter valued at approximately $130,000. Finally, nVerses Capital LLC grew its stake in shares of STAAR Surgical by 78.3% during the third quarter. nVerses Capital LLC now owns 4,100 shares of the medical instruments supplier’s stock worth $152,000 after purchasing an additional 1,800 shares during the period. Institutional investors own 96.70% of the company’s stock.

Analyst Ratings Changes

STAA has been the topic of several analyst reports. Canaccord Genuity Group cut their target price on shares of STAAR Surgical from $41.00 to $31.00 and set a “hold” rating on the stock in a report on Friday, November 1st. Stifel Nicolaus reduced their target price on shares of STAAR Surgical from $50.00 to $44.00 and set a “buy” rating for the company in a report on Monday, August 26th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of STAAR Surgical in a research report on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $43.33.

STAAR Surgical Trading Up 0.4 %

STAA opened at $28.18 on Friday. The stock has a market cap of $1.39 billion, a PE ratio of 64.05 and a beta of 0.61. The stock’s fifty day simple moving average is $30.68 and its 200 day simple moving average is $36.32. STAAR Surgical has a 1-year low of $25.88 and a 1-year high of $52.68.

STAAR Surgical Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.